Ultrasound-Guided Access Reduces Vascular Complications in Patients Undergoing Catheter Ablation for Cardiac Arrhythmias.
atrial arrhythmias
catheter ablation
ultrasound-guided vascular access
vascular access complications
ventricular arrhythmias
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
15 Nov 2022
15 Nov 2022
Historique:
received:
04
10
2022
revised:
11
11
2022
accepted:
14
11
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
27
11
2022
Statut:
epublish
Résumé
Background: Femoral vascular access using the standard anatomic landmark-guided method is often limited by peripheral artery disease and obesity. We investigated the effect of ultrasound-guided vascular puncture (UGVP) on the rate of vascular complications in patients undergoing catheter ablation for atrial or ventricular arrhythmias. Methods: The data of 479 patients (59% male, mean age 68 years ± 11 years) undergoing catheter ablation for left atrial (n = 426; 89%), right atrial (n = 28; 6%) or ventricular arrhythmias (n = 28; 6%) were analyzed. All patients were on uninterrupted oral anticoagulants and heparin was administered intravenously during the procedure. Femoral access complications were compared between patients undergoing UGVP (n = 320; 67%) and patients undergoing a conventional approach (n = 159; 33%). Complication rates were also compared between patients with a BMI of >30 kg/m2 (n = 136) and patients with a BMI < 30 kg/m2 (n = 343). Results: Total vascular access complications including mild hematomas were n = 37 (7.7%). In the conventional group n = 17 (10.7%) and in the ultrasound (US) group n = 20 (6.3%) total vascular access complications occurred (OR 0.557, 95% CI 0.283−1.096). UGVP significantly reduced the risk of hematoma > 5 cm (OR 0.382, 95% CI 0.148, 0.988) or pseudoaneurysm (OR 0.160, 95% CI 0.032, 0.804). There was no significant difference between the groups regarding retroperitoneal hematomas or AV fistulas (p > 0.05). In patients with BMI > 30 kg/m2, UGVP led to a highly relevant reduction in the risk of total vascular access complications (OR 0.138, 95% CI 0.027, 0.659), hematomas > 5 cm (OR 0.051, 95% CI 0.000, 0.466) and pseudoaneurysms (OR 0.051, 95% CI 0.000, 0.466). Conclusion: UGVP significantly reduces vascular access complications. Patients with a BMI > 30 kg/m2 seem to particularly profit from a UGVP approach.
Identifiants
pubmed: 36431243
pii: jcm11226766
doi: 10.3390/jcm11226766
pmc: PMC9696936
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Interv Card Electrophysiol. 2021 Sep;61(3):559-566
pubmed: 32809149
Clin Cardiol. 2021 Aug;44(8):1151-1160
pubmed: 34132405
Europace. 2022 Aug 25;:
pubmed: 36006798
Radiology. 1989 Dec;173(3):775-7
pubmed: 2813785
J Interv Card Electrophysiol. 2013 Aug;37(2):163-8
pubmed: 23585239
J Interv Card Electrophysiol. 2008 Aug;22(2):167-72
pubmed: 18368471
J Cardiovasc Electrophysiol. 2014 Jul;25(7):680-5
pubmed: 24602050
Europace. 2019 Mar 1;21(3):475-483
pubmed: 30304357
J Cardiovasc Electrophysiol. 2022 Apr;33(4):654-663
pubmed: 35118743
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
J Cardiovasc Dev Dis. 2022 Jan 08;9(1):
pubmed: 35050226
Heart Rhythm. 2009 Oct;6(10):1425-9
pubmed: 19968920
Europace. 2018 Jan 1;20(1):e1-e160
pubmed: 29016840
Europace. 2021 Jan 27;23(1):149-156
pubmed: 33503658
Indian Pacing Electrophysiol J. 2022 May-Jun;22(3):145-153
pubmed: 35143989
Europace. 2018 Jul 1;20(7):1107-1114
pubmed: 28575490
J Interv Card Electrophysiol. 2016 Sep;46(3):213-24
pubmed: 27001171
Am J Cardiol. 2017 Jun 1;119(11):1781-1784
pubmed: 28420481
Europace. 2020 Mar 1;22(3):388-393
pubmed: 31872249
Heart Rhythm. 2017 Sep;14(9):1336-1343
pubmed: 28479516
Europace. 2021 Nov 8;23(11):1744-1750
pubmed: 34374746
J Cardiovasc Electrophysiol. 2021 Mar;32(3):647-656
pubmed: 33428307
Heart Rhythm. 2022 Apr;19(4):648-655
pubmed: 34958942
Pacing Clin Electrophysiol. 2015 Sep;38(9):1058-65
pubmed: 26010612
Pacing Clin Electrophysiol. 2014 Aug;37(8):1023-8
pubmed: 24665892
J Interv Card Electrophysiol. 2009 Oct;26(1):59-64
pubmed: 19387807
Scand Cardiovasc J. 2014 Oct;48(5):311-6
pubmed: 25100659
J Cardiovasc Dev Dis. 2022 Apr 21;9(5):
pubmed: 35621837
J Clin Med. 2022 Jul 31;11(15):
pubmed: 35956085
Europace. 2019 Mar 1;21(3):434-439
pubmed: 30010776
Am J Cardiol. 2013 Feb 1;111(3):368-73
pubmed: 23168290
J Am Soc Echocardiogr. 2011 Dec;24(12):1291-318
pubmed: 22115322
Europace. 2019 Aug 1;21(8):1143-1144
pubmed: 31075787
Circ Arrhythm Electrophysiol. 2013 Apr;6(2):302-9
pubmed: 23443620